サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1547800

全エクソームシーケンスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Whole Exome Sequencing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 222 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
全エクソームシーケンスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 222 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

全エクソームシーケンス市場の世界需要は、調査期間2024～2032年のCAGR18.21%で、2023年の4億3,002万米ドルから2032年には約19億3,812万米ドルの市場規模に達すると推定されます。

全エクソームシーケンスまたはエクソームシーケンスは、ゲノムのタンパク質コード領域のシーケンスに使用される次世代シーケンス法（NGS）です。全エクソーム・シーケンスには2つの段階があり、第1段階はタンパク質をコードするDNAのサブセットの選択、第2段階はエクソンDNAの配列決定です。このシーケンシング法は臨床診断や学術研究に用いられています。タンパク質配列の変化の原因となる遺伝子コードバリアントを同定します。全ゲノムシーケンスは、がん研究、遺伝性疾患の原因となる遺伝子バリアントの理解と同定、集団遺伝学の理解に非常に適しています。

市場力学

ミラー症候群やアルツハイマー病などの遺伝性疾患に対する意識の高まりにより、世界の全エクソームシーケンス市場は拡大しています。全エクソームシーケンスは、ホールゲノムシーケンスに代わる費用対効果の高い手法です。したがって、低コストと高速性は、世界の全エクソームシーケンス市場を牽引している2つの要因です。市場を牽引するその他の顕著な要因としては、個別化医療への採用の増加、慢性疾患の症例の増加、ゲノムシーケンスにおけるR&Dの増加などが挙げられます。さらに、技術の進歩、革新的な科学的アプリケーションの増加、既存の主要企業による投資の増加、新規企業の市場参入などの要因も市場を促進しています。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、全エクソームシーケンスの世界市場における各セグメントを包括的に評価することもできます。全エクソームシーケンス産業の成長と動向は、この研究に全体的なアプローチを記載しています。

市場セグメンテーション

全エクソームシーケンス市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家が今後の機会を持つそれぞれの製品やサービスの対象層を特定するのに役立ちます。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける全エクソームシーケンス市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 全エクソームシーケンス-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 全エクソームシーケンスの世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 機器
  • 消耗品
  • サービス

第6章 全エクソームシーケンスの世界市場分析：技術別

  • 技術別概要
  • 実績データと予測データ
  • 技術別分析
  • 合成シーケンス
  • イオン半導体シーケンス
  • その他

第7章 全エクソームシーケンスの世界市場分析：ワークフロー別

  • ワークフロー別概要
  • 実績データと予測データ
  • ワークフロー別分析
  • プレシーケンス
  • シーケンス
  • データ分析

第8章 全エクソームシーケンスの世界市場分析：用途用

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • 臨床診断
  • 創薬・医薬品開発
  • 個別化医薬品
  • その他

第9章 全エクソームシーケンスの世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 学術研究機関
  • 病院・クリニック
  • 製薬・バイオテクノロジー企業
  • その他

第10章 全エクソームシーケンスの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 全エクソームシーケンス企業の競合情勢

  • 全エクソームシーケンス市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Illumina Inc
  • Agilent Technologies Inc
  • BGI
  • PacBio
  • Oxford Nanopore Technologies Plc.
  • Azenta US Inc.（Genewiz）
  • CD Genomics
  • Novogene Co Ltd
  • Eurofins Genomics
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Sequencing by Synthesis Market Sales By Geography (USD MN)
  • ION Semiconductor Sequencing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Workflow (USD MN)
  • Pre-Sequencing Market Sales By Geography (USD MN)
  • Sequencing Market Sales By Geography (USD MN)
  • Data Analysis Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Clinical Diagnostics Market Sales By Geography (USD MN)
  • Drug Discovery & Development Market Sales By Geography (USD MN)
  • Personalized Medicines Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Academic And Research Institutes Market Sales By Geography (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Whole Exome Sequencing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Whole Exome Sequencing Report
  • Market Research Process
  • Market Research Methodology
  • Global Whole Exome Sequencing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Sequencing by Synthesis Market Sales By Geography (USD MN)
  • ION Semiconductor Sequencing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Workflow (USD MN)
  • Pre-Sequencing Market Sales By Geography (USD MN)
  • Sequencing Market Sales By Geography (USD MN)
  • Data Analysis Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Clinical Diagnostics Market Sales By Geography (USD MN)
  • Drug Discovery & Development Market Sales By Geography (USD MN)
  • Personalized Medicines Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Academic And Research Institutes Market Sales By Geography (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11213315

The global demand for Whole Exome Sequencing Market is presumed to reach the market size of nearly USD 1938.12 Million by 2032 from USD 430.02 Million in 2023 with a CAGR of 18.21% under the study period 2024-2032.

Whole Exome Sequencing or Exome Sequencing is a next-generation sequencing method (NGS) used for sequencing of the protein-coding regions of the genome. Whole Exome Sequencing involves two steps - the first step is the selection of the subset of DNA, which encodes proteins, and the second step is the sequencing of the exonic DNA. The sequencing method is used in clinical diagnostics and academic research. It identifies genetic coding variants responsible for alteration in protein sequencing. Whole-genome sequencing is highly applicable in cancer research, understanding and identification of genetic variants causing genetic diseases, and understanding population genetics.

MARKET DYNAMICS

The global Whole Exome Sequencing market is expanding due to increasing awareness about genetic diseases such as Miller's syndrome and Alzheimer's disease. Whole Exome Sequencing is a cost-effective alternative for Whole-genome sequencing. Hence low cost and high speed are the two factors that are triggering the global Whole Exome Sequencing market. The other prominent factors that are driving the market include rising adoption for personalized medicine, growing cases of chronic diseases and growing R & D in genome sequencing. Moreover, factors such as advancement in technology, a growing number of innovative scientific applications, increasing investments by existing key players, and entry of new companies in the market are also propelling the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Whole Exome Sequencing. The growth and trends of Whole Exome Sequencing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Whole Exome Sequencing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Instruments
  • Consumables
  • Services

By Technology

  • Sequencing by Synthesis
  • ION Semiconductor Sequencing
  • Others

By Workflow

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

By Application

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Personalized Medicines
  • Others

By End-use

  • Academic And Research Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Whole Exome Sequencing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Whole Exome Sequencing market include Thermo Fisher Scientific Inc., Illumina Inc, Agilent Technologies Inc, BGI, PacBio, Oxford Nanopore Technologies Plc., Azenta US Inc. (Genewiz), CD Genomics, Novogene Co Ltd, Eurofins Genomics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. WHOLE EXOME SEQUENCING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Workflow
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Instruments Historic and Forecast Sales By Regions
  • 5.5. Consumables Historic and Forecast Sales By Regions
  • 5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Technology
  • 6.4. Sequencing by Synthesis Historic and Forecast Sales By Regions
  • 6.5. ION Semiconductor Sequencing Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY WORKFLOW

  • 7.1. Overview By Workflow
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Workflow
  • 7.4. Pre-Sequencing Historic and Forecast Sales By Regions
  • 7.5. Sequencing Historic and Forecast Sales By Regions
  • 7.6. Data Analysis Historic and Forecast Sales By Regions

8. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY APPLICATION

  • 8.1. Overview By Application
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Application
  • 8.4. Clinical Diagnostics Historic and Forecast Sales By Regions
  • 8.5. Drug Discovery & Development Historic and Forecast Sales By Regions
  • 8.6. Personalized Medicines Historic and Forecast Sales By Regions
  • 8.7. Others Historic and Forecast Sales By Regions

9. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-use
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By End-use
  • 9.4. Academic And Research Institutes Historic and Forecast Sales By Regions
  • 9.5. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 9.6. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 9.7. Others Historic and Forecast Sales By Regions

10. GLOBAL WHOLE EXOME SEQUENCING MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE WHOLE EXOME SEQUENCING COMPANIES

  • 11.1. Whole Exome Sequencing Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF WHOLE EXOME SEQUENCING INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Thermo Fisher Scientific Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Illumina Inc
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Agilent Technologies Inc
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. BGI
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. PacBio
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Oxford Nanopore Technologies Plc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Azenta US Inc. (Genewiz)
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. CD Genomics
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Novogene Co Ltd
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Eurofins Genomics
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies